Chroniques génomiques - Les limites de l’« oncologie de
                    précision »

Jordan, Bertrand

doi:10.1051/medsci/2019177

dc.contributor.author	Jordan, Bertrand	-
dc.date.accessioned	2020-12-07T10:27:27Z
dc.date.available	2020-12-07T10:27:27Z
dc.date.issued	2019
dc.identifier.citation	Jordan, Bertrand ; Les limites de l’« oncologie de précision » : Chroniques génomiques, Med Sci (Paris), Vol. 35, N° 11 ; p. 905-907 ; DOI : 10.1051/medsci/2019177
dc.identifier.issn	1958-5381
dc.identifier.uri	http://hdl.handle.net/10608/10493
dc.description.abstract	The concept of precision oncology is straightforward, but the actual results of treating advanced cancer patients with the targeted drug suggested by genomic analysis have been generally disappointing, indicating that this approach is not yet ready for routine clinical practice. A number of possible improvements can and will be tested by additional clinical trials.	en
dc.language.iso	fr
dc.publisher	EDP Sciences
dc.relation.ispartof	Forum
dc.rights	Article en libre accès - License CC BY 4.0 [http://creativecommons.org/licenses/by/4.0]	fr
dc.rights	Médecine/Sciences - Inserm - SRMS	fr
dc.source	M/S. Médecine sciences [ISSN papier : 0767-0974 ; ISSN numérique : 1958-5381], Vol. 35, N° 11; p. 905-907
dc.subject.mesh	Humains	fr
dc.subject.mesh	Oncologie médicale	fr
dc.subject.mesh	Tumeurs	fr
dc.subject.mesh	Médecine de précision	fr
dc.subject.mesh	méthodes	fr
dc.subject.mesh	thérapie	fr
dc.title	Chroniques génomiques - Les limites de l’« oncologie de précision »	fr
dc.title.alternative	“Precision oncology”: not yet ready for prime time?	en
dc.type	Article
dc.contributor.affiliation	UMR 7268 ADÉS, Aix-Marseille, Université/EFS/CNRS ; CoReBio PACA, case 901, Parc scientifique de Luminy, 13288 Marseille Cedex 09, France
dc.identifier.doi	10.1051/medsci/2019177
dc.identifier.pmid	31845885